(Q36641957)

15 August 2017

1 reference

title

Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate (English)

1 reference

15 August 2017

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

4 November 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707989

4 November 2022

tumor biomarker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707989

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

4 November 2022

author name string

J. E. Oesterling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707989

4 November 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:S0022534717384914?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

https://api.elsevier.com/content/article/PII:S0022534717384914?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2938491-4

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

4 November 2022

1 reference

15 August 2017

volume

145

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

907-923

1 reference

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The significance of prostatic acid phosphatase in adenocarcinoma of the prostate

4 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Purification of a human prostate specific antigen

4 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Isolation and Characterization of Two Specific Antigens of Human Seminal Plasma

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Postcoital detection of a male-specific semen protein. Application to the investigation of rape

4 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

A simplified purification procedure for human prostate antigen

4 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

A prostate antigen in sera of prostatic cancer patients

4 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay

4 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate antigen: A new potential marker for prostatic cancer

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate-specific antigenic domain of human prostate specific antigen identified with monoclonal antibodies

4 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Human prostate-specific antigen: structural and functional similarity with serine proteases

4 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene

4 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Primary structure of a human glandular kallikrein gene

4 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Molecular cloning of human prostate specific antigen cDNA.

4 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Molecular cloning and characterization of novel prostate antigen cDNA's

4 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

4 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate antigen: a marker for human prostate epithelial cells

4 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunochemical quantitation of antigens by single radial immunodiffusion

4 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The predominant protein in human seminal coagulate

4 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Characterization of a monoclonal antibody to a conserved epitope on human seminal vesicle-specific peptides: a novel probe/marker system for semen identification

4 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunohistochemical localization of the MHS-5 antigen in principal cells of human seminal vesicle epithelium

4 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30).

4 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein

4 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The proteolytic activity of human prostate-specific antigen

4 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Dog prostate arginine esterase is related to human prostate specific antigen

4 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia

4 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen

4 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate cancer: comparison of transrectal US and digital rectal examination for screening

4 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

4 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Comparison of a Polyclonal and Monoclonal Immunoassay for PSA: Need for an International Antigen Standard

4 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

4 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients

4 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients

4 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Use of human prostate-specific antigen in monitoring prostate cancer

4 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

4 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation

4 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer.

4 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers

4 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer

4 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Differences in values obtained with 2 assays of prostate specific antigen.

4 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Reappraisal of the causes of the "hook effect" in two-site immunoradiometric assays.

4 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase

4 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia

4 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

4 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Intraductal dysplasia: a premalignant lesion of the prostate

4 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic intraepithelial neoplasia (PIN)

4 November 2022

75

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia

4 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis

4 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic intraepithelial neoplasia and prostate-specific antigen

4 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The value of serum prostate specific antigen determinations before and after radical prostatectomy

4 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

4 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters

4 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)

4 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients

4 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice

4 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?

4 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunoperoxidase localization of prostate-specific antigen

4 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Pre-Treatment and Post-Treatment Evaluation of Prostatic Adenocarcinoma for Prostatic Specific Acid Phosphatase and Prostatic Specific Antigen by Immunohistochemistry

4 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Evaluation of Prostate Specific Acid Phosphatase and Prostate Specific Antigen in Identification of Prostatic Cancer

4 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen

4 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications

4 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice

4 November 2022

104

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates

4 November 2022

106

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Demonstration of the prostatic origin of metastases.An immunohistochemical method for formalin-fixed embedded tissue

4 November 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry

4 November 2022

108

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Immunohistochemical diagnosis of prostatic cancer with metastasis

4 November 2022

109

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic origin of tumors. An immunohistochemical study

4 November 2022

110

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Prostatic acid phosphatase activity in carcinoid tumors

4 November 2022

111

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase

4 November 2022

112

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)38491-4

4 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1707989

4 November 2022

1 reference